Pharmacists in Shorewood, WI Accepting Medicare

10 Pharmacists found. Showing 1 - 10

Alisa Renee Conroy, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4081 N Oakland Ave, Shorewood, WI 53211 Phone: 414-961-2001    Fax: 414-961-9924

Michael John Okray, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3512 N Oakland Ave, Shorewood, WI 53211 Phone: 414-332-9300    Fax: 414-332-3111

Mr. Marvin Aaron Rudack, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3512 N Oakland Ave, Shorewood, WI 53211 Phone: 414-332-9300

Ms. Shelley Renee Budney-weber, RPH Pharmacist - Pharmacotherapy Medicare: Not Enrolled in Medicare Practice Location: 4081 N Oakland Ave, Shorewood, WI 53211 Phone: 414-961-2001    Fax: 414-961-9924

Mazen Seddick, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3512 N Oakland Ave, Shorewood, WI 53211 Phone: 414-627-4444    Fax: 414-296-8456

Stephanie Lynn Emery Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4035 N Oakland Ave, Shorewood, WI 53211 Phone: 414-961-2001    Fax: 414-961-9924

Mrs. Cornelia Lindeque, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4081 N Oakland Ave, Shorewood, WI 53211 Phone: 414-961-2001    Fax: 414-961-9924

Paulynn Mary Weber, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4081 N Oakland Ave, Shorewood, WI 53211 Phone: 414-961-2001

Stephanie Ann Rennicke Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4035 N Oakland Ave, Shorewood, WI 53211 Phone: 414-961-2001

Shizuki Ide, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4035 N Oakland Ave, Shorewood, WI 53211 Phone: 414-961-2001

News Archive

Virginia Commonwealth University receives $1.8M grant to study biology of allergic disease

The National Institutes of Health has awarded Virginia Commonwealth University a grant totaling $1.8 million to study the biology of allergic disease - work which may one day point researchers to the development of therapies to fight asthma, allergy and inflammatory conditions such as rheumatoid arthritis, multiple sclerosis and heart disease.

Kamada initiates Phase 2/3 clinical trial of Glassia to treat pediatric patients with T1D

Kamada Ltd. (NASDAQ:KMDA) (TASE:KMDA), a plasma-derived protein therapeutics company focused on orphan indications, announces the initiation of a Phase 2/3 clinical trial of Glassia®, the Company's proprietary human Alpha-1 Antitrypsin (AAT), to treat newly diagnosed pediatric patients with type 1 diabetes (T1D).

BioDelivery Sciences' partner Meda to launch ONSOLIS for managing breakthrough pain

BioDelivery Sciences International, Inc. announced that its commercial partner Meda will launch the FDA-approved ONSOLIS (fentanyl buccal soluble film) next week for the management of breakthrough pain (BTP) in patients with cancer, eighteen years of age and older, who are already receiving and who are tolerant to opioid therapy for their underlying persistent cancer pain.

Vitamin D supplementation may affect intestinal barrier dysfunction associated with Crohn's disease

New research published in this month's edition of United European Gastroenterology journal suggests that supplementation with vitamin D may impact on the intestinal barrier dysfunction associated with Crohn's disease, and could have a role in the treatment of the condition.

Arrow LionHeart heart-assist device patient receives heart transplant

Gayle Snider, the first U.S. patient to go home from the hospital with an Arrow LionHeart heart-assist device, received a heart transplant Saturday, May 22, at Penn State Milton S. Hershey Medical Center.

Read more Medical News

› Verified 5 days ago